CL2021001243A1 - Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445) - Google Patents
Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445)Info
- Publication number
- CL2021001243A1 CL2021001243A1 CL2021001243A CL2021001243A CL2021001243A1 CL 2021001243 A1 CL2021001243 A1 CL 2021001243A1 CL 2021001243 A CL2021001243 A CL 2021001243A CL 2021001243 A CL2021001243 A CL 2021001243A CL 2021001243 A1 CL2021001243 A1 CL 2021001243A1
- Authority
- CL
- Chile
- Prior art keywords
- carboxamide
- loss
- bicyclo
- thiophene
- heptane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Fertilizers (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
En la presente solicitud se divulga compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio Kv7.4, sus composiciones farmacéuticas y su uso para preparar un medicamento útil en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de Corti.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17158326.3A EP3366683A1 (en) | 2017-02-28 | 2017-02-28 | Cyclic amides, acteamides and ureas useful as potassium channel openers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2021001243A1 true CL2021001243A1 (es) | 2021-10-22 |
Family
ID=58192162
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019002445A CL2019002445A1 (es) | 2017-02-28 | 2019-08-26 | Nuevos compuestos útiles como abridores de canal de potasio. |
| CL2021001243A CL2021001243A1 (es) | 2017-02-28 | 2021-05-12 | Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445) |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019002445A CL2019002445A1 (es) | 2017-02-28 | 2019-08-26 | Nuevos compuestos útiles como abridores de canal de potasio. |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US11034665B2 (es) |
| EP (3) | EP3366683A1 (es) |
| JP (3) | JP6795713B2 (es) |
| KR (2) | KR102443685B1 (es) |
| CN (2) | CN114105942B (es) |
| AU (2) | AU2018227005B2 (es) |
| BR (2) | BR112019017184B1 (es) |
| CA (2) | CA3238405A1 (es) |
| CL (2) | CL2019002445A1 (es) |
| CY (2) | CY1123114T1 (es) |
| DK (2) | DK3484863T3 (es) |
| ES (2) | ES2813064T3 (es) |
| HR (2) | HRP20201159T1 (es) |
| HU (2) | HUE052703T2 (es) |
| IL (1) | IL268931B (es) |
| LT (2) | LT3484863T (es) |
| MX (2) | MX2019010169A (es) |
| PH (1) | PH12019550146A1 (es) |
| PL (2) | PL3484863T3 (es) |
| PT (2) | PT3484863T (es) |
| RS (2) | RS60648B1 (es) |
| SI (2) | SI3484863T1 (es) |
| WO (1) | WO2018158256A2 (es) |
| ZA (1) | ZA201905198B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3366683A1 (en) * | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
| US20230136562A1 (en) | 2020-04-29 | 2023-05-04 | Idorsia Pharmaceuticals Ltd | Spirourea derivatives |
| KR20230029813A (ko) | 2020-06-25 | 2023-03-03 | 이도르시아 파마슈티컬스 리미티드 | 시클로부틸-우레아 유도체 |
| US20240009149A1 (en) * | 2020-11-19 | 2024-01-11 | Acousia Therapeutics Gmbh | Non-aqueous gel composition |
| EP4279061A1 (en) * | 2022-05-18 | 2023-11-22 | Acousia Therapeutics GmbH | Aqueous gel composition |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0594034A (ja) | 1990-06-29 | 1993-04-16 | Xerox Corp | クラツクのない電子写真画像形成デバイス |
| EP0957099B1 (en) * | 1998-04-15 | 2002-11-20 | Pfizer Products Inc. | Heterocyclic carboxamides |
| DE19929076A1 (de) | 1999-06-25 | 2000-12-28 | Aventis Pharma Gmbh | Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10061876A1 (de) * | 2000-12-12 | 2002-06-20 | Aventis Pharma Gmbh | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| AR033095A1 (es) | 2001-04-04 | 2003-12-03 | Wyeth Corp | Metodos para el tratamiento de motilidad gastrica hiperactiva |
| US7273866B2 (en) * | 2002-12-20 | 2007-09-25 | Bristol-Myers Squibb Company | 2-aryl thiazole derivatives as KCNQ modulators |
| AU2004222626B2 (en) | 2003-03-21 | 2010-06-24 | H. Lundbeck A/S | Substituted p-diaminobenzene derivatives |
| TWI349666B (en) | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
| UA89503C2 (uk) | 2004-09-13 | 2010-02-10 | Х. Луннбек А/С | Заміщені похідні аніліну |
| US20060188445A1 (en) | 2005-02-22 | 2006-08-24 | Fred Hutchinson Cancer Research Center | Assay for compounds that protect against sensory hair cell death and compounds identified by same |
| US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| WO2007087424A2 (en) | 2006-01-25 | 2007-08-02 | The Johns Hopkins University | Method of treating kcnq related disorders using organozinc compounds |
| WO2007138112A2 (en) * | 2006-06-01 | 2007-12-06 | Devgen N.V. | Compounds that interact with ion channels, in particular with ion channels from the kv family |
| US20090118274A1 (en) * | 2007-02-15 | 2009-05-07 | Darin Allen | Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| DE102007032436B4 (de) | 2007-07-10 | 2009-07-16 | Heraeus Electro-Nite International N.V. | Vorrichtung zum Sammeln von Gasen in Metallschmelzen |
| EP2185149A1 (en) * | 2007-08-01 | 2010-05-19 | H. Lundbeck A/S | Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| BRPI0818581A2 (pt) | 2007-10-17 | 2015-07-21 | Sanofi Aventis | Carboxamidas n-fenil-bipirrolidina substituídas e uso terapêutico das mesmas |
| EP2231602A1 (en) * | 2007-12-13 | 2010-09-29 | Amgen, Inc | Gamma secretase modulators |
| US7786171B2 (en) * | 2008-04-04 | 2010-08-31 | Abbott Laboratories | Amide derivatives as positive allosteric modulators and methods of use thereof |
| TW201038572A (en) | 2009-03-25 | 2010-11-01 | Gruenenthal Gmbh | Substituted spiro-amide compounds |
| EP2438037A1 (en) * | 2009-06-04 | 2012-04-11 | Merz Pharma GmbH & Co. KGaA | Glycine b antagonists |
| WO2011085351A2 (en) * | 2010-01-11 | 2011-07-14 | The Johns Hopkins University | Method of treating kcnq related disorders |
| DE102010007281A1 (de) * | 2010-02-08 | 2011-08-11 | EMC microcollections GmbH, 72070 | Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger |
| US8586604B2 (en) * | 2010-08-20 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
| TW201217312A (en) * | 2010-09-22 | 2012-05-01 | Gruenenthal Gmbh | Substituted benzamide compounds |
| ES2656972T3 (es) * | 2012-02-23 | 2018-03-01 | Vanderbilt University | Análogos de 5-aminotieno [2,3-c] piridazin-6-carboxamida como moduladores alostéricos positivos del receptor de acetilcolina muscarínico M4 |
| CA2885828C (en) | 2012-09-28 | 2021-04-27 | University Of Washington Through Its Center For Commercialization | Ureido-thiophenyl derivatives, compositions thereof and methods for preventing, treating and/or protecting against sensory hair cell death |
| WO2014079850A1 (en) * | 2012-11-23 | 2014-05-30 | F. Hoffmann-La Roche Ag | Substituted heterocyclic derivatives |
| US9572815B2 (en) * | 2013-03-15 | 2017-02-21 | St. Jude Children's Research Hospital | Methods and compositions of p27KIP1 transcriptional modulators |
| PL404138A1 (pl) * | 2013-05-31 | 2014-12-08 | Warszawski Uniwersytet Medyczny | Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα |
| US20150126507A1 (en) * | 2013-09-05 | 2015-05-07 | Fate Therapeutics, Inc. | Compounds to treat hearing loss |
| CA2929194A1 (en) * | 2013-11-05 | 2015-05-14 | F. Hoffmann-La Roche Ag | 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases |
| ES2607752T3 (es) * | 2013-11-12 | 2017-04-03 | Acousia Therapeutics Gmbh | Compuestos nuevos para regeneración de células y tejidos terminalmente diferenciados |
| CN105017085B (zh) | 2014-04-28 | 2018-06-29 | 中国科学院上海药物研究所 | 一类kcnq钾通道激动剂、其制备方法和用途 |
| US9493482B2 (en) * | 2015-02-06 | 2016-11-15 | University Of Washington | Compounds and methods for preventing or treating sensory hair cell death |
| GB201601301D0 (en) * | 2016-01-25 | 2016-03-09 | Takeda Pharmaceutical | Novel compounds |
| EP3366683A1 (en) * | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
-
2017
- 2017-02-28 EP EP17158326.3A patent/EP3366683A1/en not_active Withdrawn
-
2018
- 2018-02-27 ES ES18707374T patent/ES2813064T3/es active Active
- 2018-02-27 DK DK18707374.7T patent/DK3484863T3/da active
- 2018-02-27 MX MX2019010169A patent/MX2019010169A/es unknown
- 2018-02-27 EP EP18707374.7A patent/EP3484863B1/en active Active
- 2018-02-27 PL PL18707374T patent/PL3484863T3/pl unknown
- 2018-02-27 HU HUE19179900A patent/HUE052703T2/hu unknown
- 2018-02-27 JP JP2019567399A patent/JP6795713B2/ja active Active
- 2018-02-27 SI SI201830113T patent/SI3484863T1/sl unknown
- 2018-02-27 CN CN202111376413.6A patent/CN114105942B/zh active Active
- 2018-02-27 LT LTEP18707374.7T patent/LT3484863T/lt unknown
- 2018-02-27 RS RS20200895A patent/RS60648B1/sr unknown
- 2018-02-27 AU AU2018227005A patent/AU2018227005B2/en active Active
- 2018-02-27 EP EP19179900.6A patent/EP3567034B1/en active Active
- 2018-02-27 CA CA3238405A patent/CA3238405A1/en active Pending
- 2018-02-27 DK DK19179900.6T patent/DK3567034T3/da active
- 2018-02-27 LT LTEP19179900.6T patent/LT3567034T/lt unknown
- 2018-02-27 HU HUE18707374A patent/HUE051854T2/hu unknown
- 2018-02-27 KR KR1020217035304A patent/KR102443685B1/ko active IP Right Grant
- 2018-02-27 SI SI201830189T patent/SI3567034T1/sl unknown
- 2018-02-27 RS RS20201546A patent/RS61254B1/sr unknown
- 2018-02-27 CA CA3052359A patent/CA3052359A1/en active Pending
- 2018-02-27 BR BR112019017184-3A patent/BR112019017184B1/pt active IP Right Grant
- 2018-02-27 WO PCT/EP2018/054820 patent/WO2018158256A2/en active Application Filing
- 2018-02-27 BR BR122020025103-4A patent/BR122020025103B1/pt active IP Right Grant
- 2018-02-27 KR KR1020197023369A patent/KR102382795B1/ko active IP Right Grant
- 2018-02-27 PT PT187073747T patent/PT3484863T/pt unknown
- 2018-02-27 CN CN201880014217.4A patent/CN110312710B/zh active Active
- 2018-02-27 PL PL19179900T patent/PL3567034T3/pl unknown
- 2018-02-27 PT PT191799006T patent/PT3567034T/pt unknown
- 2018-02-27 ES ES19179900T patent/ES2846772T3/es active Active
- 2018-02-27 MX MX2020010866A patent/MX2020010866A/es unknown
- 2018-02-27 US US16/487,933 patent/US11034665B2/en active Active
-
2019
- 2019-08-06 ZA ZA2019/05198A patent/ZA201905198B/en unknown
- 2019-08-19 PH PH12019550146A patent/PH12019550146A1/en unknown
- 2019-08-26 CL CL2019002445A patent/CL2019002445A1/es unknown
- 2019-08-26 IL IL268931A patent/IL268931B/en unknown
-
2020
- 2020-07-09 CY CY20201100634T patent/CY1123114T1/el unknown
- 2020-07-23 HR HRP20201159TT patent/HRP20201159T1/hr unknown
- 2020-09-29 JP JP2020163507A patent/JP2021008479A/ja not_active Withdrawn
- 2020-11-09 CY CY20201101052T patent/CY1123488T1/el unknown
- 2020-12-07 HR HRP20201961TT patent/HRP20201961T1/hr unknown
-
2021
- 2021-05-11 US US17/316,823 patent/US11884642B2/en active Active
- 2021-05-12 CL CL2021001243A patent/CL2021001243A1/es unknown
- 2021-10-22 AU AU2021254653A patent/AU2021254653B2/en active Active
-
2022
- 2022-08-01 JP JP2022122598A patent/JP7474289B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021001243A1 (es) | Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445) | |
| PH12018550062A1 (en) | Topical film-forming spray | |
| CL2021000415A1 (es) | Vesículas derivadas de lactobacillus paracasei y uso de las mismas | |
| UA107653C2 (en) | Extract of aerial parts of oats harvested before ear emergence | |
| EA201692334A1 (ru) | Кортикостероидные композиции для местного применения | |
| EP3829569A4 (en) | SPINOSYN FORMULATIONS FOR THE TREATMENT OF DEMODEX-INDUCED EYE AND FACIAL DISORDERS | |
| EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| BR112017002879A2 (pt) | balões revestidos e conjuntos de balões revestidos e métodos relacionados de uso e fabricação | |
| MX2021012659A (es) | Composiciones de seda para el cuidado del cabello. | |
| WO2018183631A8 (en) | Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same | |
| ECSP18060864A (es) | Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano | |
| CO2017003290A2 (es) | Composiciones y kits para desbridación enzimática y metodos de uso de los mismos | |
| PH12019500949A1 (en) | Ror-gamma modulators | |
| CO2020004407A2 (es) | Formulaciones de espora de nutriente y usos de las mismas | |
| BR112017005282A2 (pt) | produtos para tratamento de pele | |
| WO2016030841A3 (en) | Novel care and/or makeup device comprising a composition of gel/gel architecture | |
| GEP20237486B (en) | Formulations of copanlisib | |
| WO2020194087A3 (en) | Extended release pharmaceutical formulation | |
| CL2019003503A1 (es) | Composiciones sinérgicas que comprenden dimiracetam (r) (1) y dimiracetam (s) (2) en una proporción no racémica. | |
| MX2019011951A (es) | Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas. | |
| PH12018501508A1 (en) | Depilatory compositions | |
| EA201991185A1 (ru) | Композиции для личной гигиены, содержащие цистин | |
| WO2017160694A3 (en) | Compositions for providing vitamin d to the skin | |
| CO2019014831A2 (es) | Nuevas formulaciones orales de belinostat | |
| EP3773932A4 (en) | SKIN CARE COMPOSITIONS AND THEIR APPLICATIONS |